4//SEC Filing
Mazel Sidney 4
Accession 0001123292-07-000550
CIK 0000873591other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:33 PM ET
Size
8.4 KB
Accession
0001123292-07-000550
Insider Transaction Report
Form 4
Mazel Sidney
SVP, Product Planning
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-06-18−50,000→ 0 totalExercise: $31.25Exp: 2017-02-14→ Common Stock (50,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-06-18−60,000→ 0 totalExercise: $29.60Exp: 2016-06-11→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]This option, which provided for vesting with respect to 1/4 of the shares on 06/12/2007 and with respect to the remaining shares in equal quarterly installments thereafter, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $28.40 per share, representing the difference between the exercise price of the option and $58.00 per share.
- [F2]This option, which provided for vesting in equal quarterly installments beginning 5/15/2007, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share.
Documents
Issuer
MEDIMMUNE INC /DE
CIK 0000873591
Entity typeother
Related Parties
1- filerCIK 0001365774
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:33 PM ET
- Size
- 8.4 KB